How Durable Is Functional Cure (Hepatitis B Surface Antigen Loss) in Patients With Chronic Hepatitis B Treated With Current Antivirals?

How Durable Is Functional Cure (Hepatitis B Surface Antigen Loss) in Patients With Chronic Hepatitis B Treated With Current Antivirals?

Bibliographic Details
Main Authors:	Alessandro Loglio, Pietro Lampertico
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	Hepatology Communications
Online Access:	https://doi.org/10.1002/hep4.1476

Similar Items

IL28B Polymorphisms in Interferon-Treated Patients with Chronic Hepatitis B
by: Mauro Vigano, et al.
Published: (2013-12-01)

Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
by: Anna S. Lok, et al.
Published: (2020-01-01)

Functional cure for chronic hepatitis B: accessibility, durability, and prognosis
by: Aixin Song, et al.
Published: (2021-06-01)

Challenges and strategies of antiviral therapy for chronic hepatitis B-how to achieve the maximization of clinical cure?
by: WANG Weijing, et al.
Published: (2017-08-01)

How to compare antivirals in the treatment of chronic hepatitis B?
by: Leblebicioglu Hakan, et al.
Published: (2009-03-01)

Clinical implications of HBsAg quantification in patients with chronic hepatitis B
by: Mauro Viganò, et al.
Published: (2012-01-01)

Antiviral therapy for chronic hepatitis B: current status and perspectives
by: FAN Rong, et al.
Published: (2016-11-01)

Severe hepatitis B reactivation during direct-acting antiviral treatment in “the absence” of hepatitis B surface antigen
by: Lydia Sastre, et al.
Published: (2019-02-01)

Review: Current status of antiviral therapy for hepatitis B
by: Daryl T.-Y. Lau, et al.
Published: (2008-07-01)

Current research on adherence to antiviral therapy in patients with chronic hepatitis B
by: XU Manman, et al.
Published: (2015-10-01)

New antivirals for hepatitis B
by: Vicente Soriano
Published: (2018-05-01)

Antiviral therapy of chronic hepatitis B in children
by: ZHU Shishu, et al.
Published: (2015-08-01)

Functional cure of chronic hepatitis B – predictable?
by: Wolfram Gerlich
Published: (2021-08-01)

Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes
by: Christine Y.L. Tham, et al.
Published: (2020-07-01)

Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B
by: Han Ah Lee, et al.
Published: (2016-09-01)

High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B.
by: Wai-Kay Seto, et al.
Published: (2012-01-01)

Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B
by: Ming-Hui Li, et al.
Published: (2018-01-01)

Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment
by: Ming-Hui Li, et al.
Published: (2017-01-01)

The expert consensus on clinical cure (functional cure) of chronic hepatitis B
by: Chinese Society of Infectious Disease, Chinese Society of Hepatology, Chinese Medical Association
Published: (2019-08-01)

Clinical features of chronic hepatitis B patients with low hepatitis B surface antigen levels and determinants of hepatitis B surface antigen seroclearance
by: Hideaki Taniguchi, et al.
Published: (2020-08-01)

Another oral antiviral treatment, but still far away from hepatitis B virus cure
by: Tai-Chung Tseng
Published: (2021-04-01)

Evaluation of antiviral - passive - active immunization (“sandwich”) therapeutic strategy for functional cure of chronic hepatitis B in mice
by: Bisheng Shi, et al.
Published: (2019-11-01)

Thyroid dysfunction is associated with the loss of hepatitis B surface antigen in patients with chronic hepatitis B undergoing treatment with α-interferon
by: Wenfan Luo, et al.
Published: (2021-06-01)

Functional cure of chronic hepatitis B: Efforts and prospects
by: Zhishuo Mo, et al.
Published: (2020-03-01)

Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patients
by: Chia-Chi Wang, et al.
Published: (2014-11-01)

Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B
by: Mi Sung Park, et al.
Published: (2013-03-01)

Functional cure of chronic hepatitis B from the perspective of specific immune cells for hepatitis B virus
by: LIU Xiaoju
Published: (2020-05-01)

Hepatitis C can be cured: will hepatitis B become next?
by: V P Chulanov, et al.
Published: (2017-11-01)

Hepatitis B surface antigen and antibody to hepatitis B surface antigen^^ in cerebrospinal fluid
by: LIU, JIN-KUAN, et al.
Published: (1986)

Usefulness of a Hepatitis B Surface Antigen-Based Model for the Prediction of Functional Cure in Patients with Chronic Hepatitis B Virus Infection Treated with Nucleos(t)ide Analogues: A Real-World Study
by: Gian Paolo Caviglia, et al.
Published: (2021-07-01)

Hepatitis B antigen and antibodies
by: Moodie, John Wykeham
Published: (2017)

Evolution of antiviral treatment chronic for hepatitis B, C and D
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

Prophylactic Antiviral Treatment in Immunosuppressed Chronic Hepatitis B Patients
by: Eileen L. Yoon
Published: (2019-11-01)

The treatment of chronic hepatitis B: Focus on adefovir-like antivirals
by: Hans Ludger Tillmann
Published: (2008-09-01)

Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections
by: Erik De Clercq, et al.
Published: (2010-05-01)

Antiviral Treatment among Pregnant Women with Chronic Hepatitis B
by: Lin Fan, et al.
Published: (2014-01-01)

MONITORING OF LONG-TERM ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS B
by: A. A. Sukhoruk, et al.
Published: (2018-12-01)

Novel Antivirals in Clinical Development for Chronic Hepatitis B Infection
by: Lung-Yi Mak, et al.
Published: (2021-06-01)

Clinical studies of new antiviral drugs for chronic hepatitis B
by: ZHANG Hong
Published: (2021-05-01)

The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology.
by: Ashish Goyal, et al.
Published: (2014-01-01)